Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Quintiles Invests in Kareus for Phase I Trials of Alzheimer and Type 2 Diabetes Treatments

Partner will conduct proof-of-relevance studies with Kareus’ lead AD candidate KU-046 and insulin sensitizer for diabetes.

Forward this item to a colleague:


 
   

(Separate multiple addresses by commas)

   

(Separate multiple addresses by commas)

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »